Cargando…

Complementary and alternative medicine treatments for common skin diseases: A systematic review and meta-analysis

BACKGROUND: Complementary and alternative medicine (CAM) treatments are growing in popularity as alternative treatments for common skin conditions. OBJECTIVES: To perform a systematic review and meta-analysis to determine the tolerability and treatment response to CAM treatments in acne, atopic derm...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Virginia A., Patel, Payal M., Wilson, Claire, Wang, Hongnan, Ashack, Kurt A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362305/
https://www.ncbi.nlm.nih.gov/pubmed/34409356
http://dx.doi.org/10.1016/j.jdin.2020.11.001
Descripción
Sumario:BACKGROUND: Complementary and alternative medicine (CAM) treatments are growing in popularity as alternative treatments for common skin conditions. OBJECTIVES: To perform a systematic review and meta-analysis to determine the tolerability and treatment response to CAM treatments in acne, atopic dermatitis (AD), and psoriasis. METHODS: PubMed/Medline and Embase databases were searched to identify eligible studies measuring the effects of CAM in acne, AD, and psoriasis. Effect size with 95% confidence interval (CI) was estimated using the random-effect model. RESULTS: The search yielded 417 articles; 40 studies met the inclusion criteria. The quantitative results of CAM treatment showed a standard mean difference (SMD) of 3.78 (95% CI [−0.01, 7.57]) and 0.58 (95% CI [−6.99, 8.15]) in the acne total lesion count, a SMD of −0.70 (95% CI [−1.19, −0.21]) in the eczema area and severity index score and a SMD of 0.94 (95% CI [−0.83, 2.71]) in the scoring of atopic dermatitis score for AD, and a SMD of 3.04 (95% CI [−0.35, 6.43]) and 5.16 (95% CI [−0.52, 10.85]) in the Psoriasis Area Severity Index score for psoriasis. LIMITATIONS: Differences between the study designs, sample sizes, outcome measures, and treatment durations limit the generalizability of data. CONCLUSIONS: Based on our quantitative findings we conclude that there is insufficient evidence to support the efficacy and the recommendation of CAM for acne, AD, and psoriasis.